期刊文献+

pEGFP-N1-APOE ε2重组质粒的构建与鉴定

Construction and verification of pEGFP-N1-APOE ε2 recombinant plasmid
下载PDF
导出
摘要 目的构建pEGFP-N1-APOEε2真核表达重组质粒。方法应用基因定点突变手段,根据载脂蛋白E(apolipoprotein E,ApoE)基因cDNA克隆基因序列和表达载体增强绿色荧光蛋白真核表达载体(pEGFP-N1)质粒上的多克隆位点设计引物,对质粒APOE基因cDNA克隆(pMD18-T-APOE3)进行基因定点突变,得到含有APOE2基因的目的片段,将此目的片段插入载体启动子下游,与增强型绿色荧光蛋白(EGFP)的基因融合。重组质粒经菌液PCR、限制性内切酶酶切和测序,鉴定目的基因是否成功插入pEGFP-N1质粒。结果对所得pEGFP-N1-APOEε2质粒插入部分测序结果显示,pEGFP-N1-APOEε2质粒的方向及序列正确,阅读框正确无误,表明APOEε2基因定点突变正确,重组pEGFP-N1-APOEε2质粒构建成功。结论成功构建了pEGFP-N1-APOEε2真核表达重组质粒。 Objective To construct enhanced green fluorescent protein(EGFP)labled eukaryotic expression recombinant plasmid of APOEε2gene.Methods According to the sequence of cDNA cloning gene of APOE gene and the multiple clone site of the expression vector pEGFP-N1 plasmid,two specific pairs of primers were desinged and synthesized by site-directed mutation.PCR amplification was carried out on the pMD18-TAPOE3,and an target fragment was acquired.The target fragment was inserted into the carrier promoter downstream and was fused into EGFP gene fusion.The recombinant plasmid was verified by PCR of the bacterium liquid,restriction enzyme digestion and gene sequencing.Results The inserted part of pEGFP-N1-APOEε2plasmid showed that the direction and sequence pEGFP-N1-APOEε2plasmid and the reading frame were correct.The results showed that site-directed mutagenesis of APOE ε2 was correct and recombinant pEGFP-N1-ApoEε2 plasmid was successful.Conclusions The pEGFP-N1-APOEε2eukaryotic expression recombinant plasmid was successfully constructed
出处 《中国神经免疫学和神经病学杂志》 CAS 2015年第4期237-240,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 辽宁省自然科学基金计划(201102105)
关键词 APOEε2基因 真核表达质粒 基因重组 绿色荧光蛋白 APOEε2gene eukaryotic expression plasmid genetic recombination green fluorescent protein
  • 相关文献

参考文献14

  • 1Pericak Vance MA, Bebout JL, Gaskell PC, et al. Linkage studies in familial Alzheimer disease= evidence for chromo- some 19 linkage[J]. AmJ HumGenet, 1991,48:1034-1050.
  • 2Strittmatter WJ, Saunders AM, Schmechel D, et al. Apoli- poprotein-E, high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease[J]. Proc Natl Acad Sci USA, 1993, 90: 1977 1981.
  • 3Mahley RW, Rail SC Jr. Is epsilon4 the ancestral human apoEallele? [J]. NeurobiolAging, 1999,20:429 430.
  • 4Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein-E type-4 allele and the risk of Alzheimer~s disease in late onsel families[J]. Science, 1993, 261: 921- 923.
  • 5Farrer LA, Cupples LA, Haines J[., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein Egenotype and Alzheimer disease: a meta analysis[J].JAMA, 1997, 278: 1349-1356.
  • 6Chartier-Harlin MC, Parfitt M, Legrain S, et al. Apolipopro- tein Et4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer' s disease: analysis of the 19q13.2 chromosomal region[J]. Hum Mol Genet, 1994,3: 569-574.
  • 7Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease[J]. Nature Genet, 1994, 7:180-184.
  • 8Dodart JC, Marr RA, Koistinaho M, et al. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer~s disease[J].Proc Natl Acad Sci USA, 2005, 102(4):1211-1216.
  • 9Alagiakrishnan K, Gill SS, Fagarasanu A, et al. Genetics and epigenetics of Alzheimer's disease [J].Postgrad Med J, 2012, 88: 522-529.
  • 10Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease[J].Nat Rev Neurology, 2011,7(3) : 137-152.

二级参考文献6

  • 1Vincent A. Unravelling the pathogenesis of myasthenia gravis [J]. Nat RevImmunol, 2002, 2(10): 797-804.
  • 2Hodgkin PD, Heath WR, Baxter AG. The clonal selection theory: 50 years since the revolution[J]. Nat Immunol, 2007, 8(10): 1019-1026.
  • 3Zhu D, Kepley CL, Zhang M, globulin Fc gamma Fc epsilon hibits Fc epsilon RI-mediated 2002, 8(5) :518-521.
  • 4Barchan D, Souroujon MC, Im SH, et al. Antigen-specific modulation of experimental myasthenia gravis: nasal toleriza- tion with recombinant fragments of the human acetylcholine receptor alpha-subunit[J].Proc Natl Acad Sci USA, 1999, 96(14): 8086-8091.
  • 5Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses[J]. Nat Rev Immunol, 2008, 8(1) : 34- 47.
  • 6Huston JS, Levinson D, Mudgett Hunter M, et al. Protein engineering of antibody binding sites: recovery of specific ac- tivity in an anti digoxin single chain Fv analogue produced in Escherichia eoli[J]. Proc Natl Acad Sci USA, 1988, 85(16): 5879-5883.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部